Characterisation of Plasmodium falciparum RESA-like protein peptides that bind specifically to erythrocytes and inhibit invasion
- PMID: 17214545
- DOI: 10.1515/BC.2007.002
Characterisation of Plasmodium falciparum RESA-like protein peptides that bind specifically to erythrocytes and inhibit invasion
Abstract
The Plasmodium falciparum ring-erythrocyte surface antigen (RESA)-like putative protein was identified and characterised. PCR and RT-PCR assays revealed that the gene encoding this protein was both present and being transcribed in P. falciparum strain FCB-2 16 h after erythrocyte invasion. Indirect immunofluorescence studies detected this protein in infected erythrocyte (IE) cytosol in dense fluorescent granules similar to Maurer's clefts at 16-20 h (parasites in ring and trophozoite stages) and very strongly on IE membranes at 22 h, suggesting that it is synthesised during early ring stages (16 h) and transported to the infected red blood cell (RBC) membrane surface during the trophozoite stage (22 h). Western blotting showed that antisera produced against polymerised synthetic peptides of this protein recognised a 72-kDa band in P. falciparum schizont lysate. P. falciparum RESA-like peptides used in normal RBC binding assays revealed that peptides 30326 ((101)NAEKI LGFDD KNILE ALDLFY(120)), 30334 ((281)RVTWK KLRTK MIKAL KKSLTY(300)) and 30342 ((431)SSPQR LKFTA GGGFC GKLRNY(450)) bind with high activity and saturability, presenting nM affinity constants. These peptides contain alpha-helical structural elements, as determined by circular dichroism, and inhibit P. falciparum in vitro invasion of normal RBCs by up to 91%, suggesting that some RESA-like protein regions are involved in intra-erythrocyte stage P. falciparum invasion.
Similar articles
-
Studies of Plasmodium falciparum rhoptry-associated membrane antigen (RAMA) protein peptides specifically binding to human RBC.Vaccine. 2008 Feb 6;26(6):853-62. doi: 10.1016/j.vaccine.2007.11.086. Epub 2007 Dec 26. Vaccine. 2008. PMID: 18191882
-
Peptides from the Plasmodium falciparum STEVOR putative protein bind with high affinity to normal human red blood cells.Peptides. 2005 Jul;26(7):1133-43. doi: 10.1016/j.peptides.2005.01.013. Epub 2005 Feb 23. Peptides. 2005. PMID: 15949631
-
Amino terminal peptides from the Plasmodium falciparum EBA-181/JESEBL protein bind specifically to erythrocytes and inhibit in vitro merozoite invasion.Biochimie. 2005 May;87(5):425-36. doi: 10.1016/j.biochi.2005.01.005. Biochimie. 2005. PMID: 15820749
-
Structure and function of candidate vaccine antigens in Plasmodium falciparum.Biochem Soc Symp. 1987;53:103-14. Biochem Soc Symp. 1987. PMID: 3332761 Review.
-
Disguising itself--insights into Plasmodium falciparum binding and immune evasion from the DBL crystal structure.Mol Biochem Parasitol. 2006 Jul;148(1):1-9. doi: 10.1016/j.molbiopara.2006.03.004. Epub 2006 Apr 4. Mol Biochem Parasitol. 2006. PMID: 16621067 Review.
Cited by
-
Purifying and Characterizing Bacterially Expressed Soluble Lactate Dehydrogenase from Plasmodium knowlesi for the Development of Anti-Malarial Drugs.Molecules. 2021 Nov 1;26(21):6625. doi: 10.3390/molecules26216625. Molecules. 2021. PMID: 34771034 Free PMC article.
-
Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model.J Immunol Res. 2019 Dec 30;2019:3832513. doi: 10.1155/2019/3832513. eCollection 2019. J Immunol Res. 2019. PMID: 32083140 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources